# Comparison of NEOVIST 370 INJ.(Iopromide 768.86mg) With Ultravist 370 INJ.(Iopromide 768.86mg) in Abdominal CT

> **NCT01654354** · — · COMPLETED · sponsor: **Seoul National University Hospital** · enrollment: 104 (actual)

## Conditions studied

- Abdominal CT

## Interventions

- **DRUG:** NEOVIST 370 INJ.(Iopromide 768.86mg)
- **DRUG:** Ultravist 370 INJ.(Iopromide 768.86mg)

## Key facts

- **NCT ID:** NCT01654354
- **Lead sponsor:** Seoul National University Hospital
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** COMPLETED
- **Start date:** 2012-07
- **Primary completion:** 2012-11
- **Final completion:** 2013-12
- **Target enrollment:** 104 (ACTUAL)
- **Last updated:** 2014-01-14


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01654354

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01654354, "Comparison of NEOVIST 370 INJ.(Iopromide 768.86mg) With Ultravist 370 INJ.(Iopromide 768.86mg) in Abdominal CT". Retrieved via AI Analytics 2026-06-24 from https://api.ai-analytics.org/clinical/NCT01654354. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*